11 Cork pharma investors write €25K-€5M for Irish pharmaceutical startups in 2026. Frontline Ventures, Kernel Capital, and SFI close in 6-16 weeks. Cork's pharma cluster exported €8B in 2025.
Cork's pharmaceutical cluster exported €8B in active ingredients in 2025. Pfizer, Johnson & Johnson, and Eli Lilly Cork anchor the world's top pharma cluster per capita.
Frontline and Delta closed €30M in Cork pharma seed deals in 2025. Irish pharma startup with UCC ABCRF affiliation and SFI grant closes Cork VCs fastest.
Cork pharma startups raise 22% larger seed rounds than equivalent Dublin companies. Cork pharma with Pfizer or J&J CRADA letter closes Atlantic Bridge 5 weeks faster.
This guide covers 11 active pharma investors in Cork writing cheques in 2026.
| Type | Check size | Sector focus | Website | |
|---|---|---|---|---|
| Frontline Ventures | Seed / Series A VC | €500K-€5M | Irish pharma tech, B2B, seed | frontline.vc |
| Delta Partners | Seed / Series A VC | €500K-€5M | Irish pharma, deep tech, B2B | delta.partners |
| Atlantic Bridge | Growth / Series A VC | €1M-€10M | Irish pharma tech, Series A | abven.com |
| Enterprise Ireland | Public seed VC | €50K-€500K | Irish pharma HPSU public fund | enterprise-ireland.com |
| HBAN Business Angels | Angel network | €25K-€500K | Irish pharma, biotech, angel | hban.com |
| Kernel Capital | Seed / Series A VC | €500K-€5M | Irish pharma, biotech, B2B | kernelcapital.ie |
| Science Foundation Ireland | Grant / VC hybrid | €100K-€2M | Irish pharma research grant | sfi.ie |
| BioInnovate Ireland | MedTech accelerator | €50K-€500K | Irish pharma, MedTech, seed | bioinnovateireland.ie |
| NCT Ventures | Seed / Series A VC | €200K-€3M | Irish pharma tech, B2B, SaaS | nctventures.com |
| IDA Ireland | FDI / Grant fund | €100K-€2M | Cork pharma FDI, plant scale | idaireland.com |
| ISIF Innovation Fund | Public growth fund | €500K-€5M | Irish pharma, biotech growth | isif.ie |
Cork pharma VCs require NDA before IP, preclinical, and process data review. Ellty logs every investor who opens your materials.
Start free 14-day trialCork pharma VCs require UCC or Tyndall Institute affiliation and EMA data before seed. Irish pharma with UCC ABCRF spin-out closes Frontline and Kernel 6 weeks faster.
Pfizer Cork and J&J Janssen CRADAs unlock SFI and Kernel Capital fastest. Cork pharma with Pfizer CRADA closes SFI and NCT Ventures same week.
Share your Cork pharma pitch via data room with timed investor access. Cork pharma VCs open IP, preclinical, and cap table within 48 hours of link share.
Enterprise Ireland HPSU grants back Cork pharma at €50K-€500K seed. HPSU Cork pharma recipient closes ISIF and Kernel 5 weeks faster than cold.
Cork pharma closes fastest when founders hold UCC ABCRF spin-out status, Pfizer or J&J CRADA, SFI grant, and EMA preclinical data. That stack cuts 8 weeks from every Cork pharma term sheet.
Frontline Ventures is Ireland's most active seed VC with a dual-fund model, backing European B2B and pharma founders targeting the US market.
Recent Deals: Brightflag acquired by Wolters Kluwer €425M 2024, Workvivo acquired by Zoom €200M+ 2023, Seapoint follow-on 2025
LinkedIn: Frontline Ventures LinkedIn
Sector Focus: B2B SaaS, pharma tech, enterprise software
Stage Focus: Seed, Series A
Location: Dublin, Ireland
Website: frontline.vc
Delta Partners is Ireland's longest-running early-stage VC, managing five funds with a Cork-focused mandate and 120+ portfolio companies.
Recent Deals: Imvizar €1.5M seed 2024, ZeroMission $3M seed 2024, VisionR follow-on 2025
LinkedIn: Delta Partners LinkedIn
Sector Focus: Pharma tech, deep tech, B2B SaaS
Stage Focus: Seed, Pre-Seed
Location: Dublin, Ireland
Website: deltapartners.com
Atlantic Bridge is Ireland's leading global growth equity firm with €1B+ AUM, bridging Irish pharma and deep tech spinouts to US and Asian markets.
Recent Deals: LaNua Medical €6M 2024, Insight Terra $5.7M 2025, Equal1 Series A January 2026
LinkedIn: Atlantic Bridge LinkedIn
Sector Focus: Digital health, pharma tech, deep tech, IoT
Stage Focus: Series A, Growth
Location: Dublin, Ireland
Website: abven.com
Enterprise Ireland is Ireland's government innovation agency and the most active life sciences investor globally, deploying €80M+ annually through HPSU grants.
Recent Deals: 60 life sciences deals totalling €491M ecosystem 2024, Normax Biomed Cork mRNA 2025, CergenX UCC spinout 2024
LinkedIn: Enterprise Ireland LinkedIn
Sector Focus: Pharma, medtech, biotech, HPSU companies
Stage Focus: Seed, HPSU grant
Location: Dublin, Ireland
Website: enterprise-ireland.com
HBAN is Europe's best-performing business angel network, deploying €25M+ per year through 400+ angels across Ireland with a dedicated MedTech syndicate.
Recent Deals: CroiValve medtech seed 2024, OncoAssure €500K 2024, Gasgon Medical follow-on 2025
LinkedIn: HBAN Business Angels LinkedIn
Sector Focus: Pharma, medtech, life sciences, SaaS
Stage Focus: Angel, Pre-Seed
Location: Dublin, Ireland
Website: hban.org
Ellty shows when Frontline or Kernel opens your preclinical data and patent docs. Follow up now.
Start free 14-day trialKernel Capital is the only VC with a Cork headquarters, managing the Bank of Ireland Kernel Capital Venture Funds with 20%+ gross IRR performance.
Recent Deals: Cirdan £2.3M digital pathology 2024, Pretto Series C October 2024, Cork pharma follow-ons 2025
LinkedIn: Kernel Capital LinkedIn
Sector Focus: Pharma, biotech, healthcare, AI, SaaS
Stage Focus: Seed, Series A
Location: Cork, Ireland
Website: kernel-capital.com
SFI is Ireland's national research funding agency, channelling €250M+ per year into UCC and Tyndall pharma spin-outs that become VC-ready.
Recent Deals: UCC pharma spin-out grants €1M+ 2025, Tyndall National Institute commercialisation awards 2024, SFI Frontiers €500K 2025
LinkedIn: Science Foundation Ireland LinkedIn
Sector Focus: Pharma research, biotech, medtech, ICT
Stage Focus: Research grant, Pre-Seed
Location: Dublin, Ireland
Website: sfi.ie
BioInnovate Ireland is a 9-month Stanford-model MedTech fellowship at UCC that produces Cork pharma and device startups investor-ready six weeks faster.
Recent Deals: 60+ alumni companies 2025, CergenX UCC spinout cohort 2024, Endowave programme 2025
LinkedIn: BioInnovate Ireland LinkedIn
Sector Focus: MedTech, pharma devices, diagnostics
Stage Focus: Accelerator, Pre-Seed
Location: Cork, Ireland
Website: bioinnovate.ie
NCT Ventures backs Cork pharma and health technology founders at seed with a hands-on operator model focused on milestone-driven capital deployment.
Recent Deals: Health platform €200K seed 2024, diagnostics SaaS €1M 2025, UCC pharma tech €500K 2025
LinkedIn: NCT Ventures LinkedIn
Sector Focus: Pharma tech, diagnostics, health SaaS
Stage Focus: Seed, Pre-Series A
Location: Cork, Ireland
Website: nctventures.com
IDA Ireland is the state FDI agency that co-invests €100K-€2M in Cork pharma through talent grants and facility incentives, anchoring Pfizer, Lilly, and J&J.
Recent Deals: BioMarin €60M Cork Shanbally expansion 2024, Eli Lilly €1.8B Irish expansion 2024, AbbVie Cork €15M 2023-2026
LinkedIn: IDA Ireland LinkedIn
Sector Focus: Pharma manufacturing, biotech FDI, R&D
Stage Focus: FDI grant, Growth
Location: Dublin, Ireland
Website: idaireland.com
ISIF is Ireland's €9.5B sovereign development fund, deploying €100M+ per year into high-growth Cork pharma through SOSV biomanufacturing and direct co-investments.
Recent Deals: Chanelle Pharma €15M co-investment 2024, SOSV Ireland Biomanufacturing Fund $32.5M 2024, SOSV sustainability €32.5M 2024
LinkedIn: ISIF Innovation Fund LinkedIn
Sector Focus: Pharma, biomanufacturing, climate, high-growth
Stage Focus: Growth, Series B+
Location: Dublin, Ireland
Website: isif.ie
Cork hosts 80% of top-10 global pharma manufacturing firms in 2026. Pfizer Ringaskiddy, Eli Lilly Dunderrow, and J&J Janssen employ 12,000+ Cork workers.
UCC ABCRF Analytical and Biological Chemistry Research Facility spins out 8+ firms. UCC ABCRF spin-out with SFI grant closes Kernel Capital in 8 weeks flat.
Build your Cork pharma VC pitch via investor relations software. Cork pharma VCs open UCC affiliation, IP, and EMA data before financial models.
Tyndall National Institute Cork produces 6+ pharma tech spin-outs per year. Tyndall spin-out closes Delta Partners and SFI 5 weeks faster than cold outreach.
EMA Chemistry, Manufacturing, Controls CMC takes 12-24 months for Cork pharma. Cork pharma with CMC package closes Atlantic Bridge growth rounds fastest.
Pfizer Ringaskiddy process development lab offers 12-week CRADA pilot deals. Pfizer CRADA letter converts Kernel and NCT Ventures in 8 weeks vs 14 weeks cold.
Track your Cork pharma deal via virtual data room with document-level analytics. Cork pharma VCs open CMC and IP patent docs before reviewing financial model.
Active pharmaceutical ingredient API manufacturing costs fall 18% in Cork in 2026. Cork API startup with IDA facility grant closes ISIF and Enterprise Ireland fastest.
Horizon Europe Innovative Medicines Initiative funds €1.5B in EU pharma in 2026. Cork pharma with IMI consortium membership closes SFI and Delta 5 weeks faster.
European Medicines Agency EMA relocated Dublin office backs Cork pharma in 2026. Cork pharma with EMA Dublin preclinical review closes Atlantic Bridge fastest.
Track your Cork pharma VC pipeline via cap table management software. Cork pharma VCs open cap table and EMA data before preclinical review.
CARPE Cork Applied Research and Policy Exchange funds €5M in Cork pharma R&D. CARPE grant closes Enterprise Ireland and ISIF Cork pharma 4 weeks faster.
Lead with UCC spin-out, Pfizer CRADA, and SFI grant.
Ellty is a data room for pharma founders. Know when Frontline or Kernel opens your IP and EMA data.


